8-K - Aquestive Therapeutics, Inc. (0001398733) (Filer)
Published . Updated .
Filed: 2026-10-19 AccNo: 0001398733-26-000063 Size: 6 MB Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year Item 9.01: Financial Statements and Exhibits
Directly affected
- AQST Aquestive Therapeutics
Named in this report.
Indirectly affected
- SPY SPDR S&P 500
The broad U.S. stock market
- TLT iShares 20+ Year Treasury Bond
Long-term U.S. government bonds
- QQQ Invesco QQQ
Large technology stocks
- GLD SPDR Gold Shares
Gold can move with the broad market
Price reaction, T-5 to T+3
Filed: 2026-10-19 AccNo: 0001398733-26-000063 Size: 6 MB Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year Item 9.01: Financial Statements and Exhibits
Source: sec-edgar
The price since 19 Oct 2026: Aquestive Therapeutics (AQST) versus the S&P 500
| Company | When | Move | Status |
|---|---|---|---|
| Aquestive Therapeutics (AQST) | that day | +6.11% | still updating |
| Aquestive Therapeutics (AQST) | three days earlier | +5.72% | final price |
| Aquestive Therapeutics (AQST) | five days earlier | +21.72% | final price |
| GLD | that day | -0.39% | still updating |
| GLD | three days earlier | +0.80% | final price |
| GLD | five days earlier | +0.53% | final price |
| QQQ | that day | +0.14% | still updating |
| QQQ | three days earlier | +1.38% | final price |
| QQQ | five days earlier | +3.53% | final price |
| SPY | that day | +0.38% | still updating |
| SPY | three days earlier | +0.67% | final price |
| SPY | five days earlier | +1.49% | final price |
| TLT | that day | +0.69% | still updating |
| TLT | three days earlier | +0.67% | final price |
| TLT | five days earlier | -1.40% | final price |
Who gains and who loses around Aquestive Therapeutics (AQST)
Companies mentioned with this story
- AQST Aquestive Therapeutics
Aquestive Therapeutics (AQST) is linked, with no stored direction, high confidence in the 19 Oct 2026 story “8-K - Aquestive Therapeutics, Inc. (0001398733) (Filer).” Reason on file: SEC 8-K filing -> direct issuer disclosure -> AQST
How “8-K - Aquestive Therapeutics, Inc. (0001398733) (Filer)” reaches Aquestive Therapeutics (AQST)
Aquestive Therapeutics (AQST) is the company in “8-K - Aquestive Therapeutics, Inc. (0001398733) (Filer),” the 19 Oct 2026 this story story.
For Aquestive Therapeutics (AQST), the reason on file says SEC 8-K filing -> direct issuer disclosure -> AQST
Dates and price levels for Aquestive Therapeutics (AQST)
AQST traded between 3.65 and 5.10 across 20 sessions. The latest close on file is 3.85.
How solid “8-K - Aquestive Therapeutics, Inc. (0001398733) (Filer)” looks
44 out of 100Price not final
“8-K - Aquestive Therapeutics, Inc. (0001398733) (Filer)” scores 44 out of 100. The score uses 1 sources, a +5.73% difference versus the S&P 500 (SPY), and 1 linked companies. The price is not final yet.